Dengue Case Assessment

Embed Size (px)

DESCRIPTION

كتيب طبي (دليل حمى الضنك) Dengue Case Assessmentللدكتور :-أحمد مبارك دعكيك رئيس قسم الباطنة بهيئة مستشفى ابن سيناء العام اعداد:-د.منى حاج باتوممقيمة بالقسم الباطني بالهيئة تصميم غلاف : محمد بن ثعلب (ابو اصيل) مدير دائرة الاعلام والتثقيف الصحي بالهيئةاصدار :- هيئة مستشفى ابن سيناء العام (2016)

Citation preview

  • 1

  • 2

    Dengue case assessment

  • 3

    Dengue case assesment

    Warning sign of dengue fever:- Abdominal pain or tenderness Persistent vomiting Clinical fluid accumulation Mucosal bleed Lethargy; restlessness Liver enlargement >2cm Laboratory: Increase in HCT concurrent with rapid decrease in

    platelet count.

    Probable Dengue

    Live in / travel to dengue endemic area Fever and 2 of the following criteria:

    Nausea, vomiting Rash Aches and pains Tourniquet test +ve Leucopenia ,thrombocytopenia Any warning sign

  • 4

    Tourniquet Test

    Febrile phase

    Sudden onset of high-grade fever

    Lasts for 2-7 days facial flushing skin erythema generalized body ache myalgia and arthralgia headache Sore throat, injected

    pharynx, and conjunctival injection

    anorexia, nausea and vomiting

    Critical phase temperature drops to 37.5-38

    (days 3-7) (+) increase in capillary

    permeability with increasing hematocrit levels

    significant plasma leakage lasts for 24-48 hours

    progressive leukopenia followed by rapid decrease in platelet precedes plasma leakage

    if (-) increase in capillary permeability improve

    if (+) increase in capillary permeability pleural effusion and ascites

    degree of increase above the baseline hematocrit reflects the severity of plasma leakage

    shock: critical volume of plasma is lost

    temperature may be subnormal

    prolonged shock organ hypo perfusion organ impairment, metabolic acidosis, and DIC severe hemorrhage

    severe hepatitis, encephalitis or myocarditis

    Recovery phase

    gradual reabsorption of extravascular compartment fluid (48-72 hours)

    general well-being improves, appetite returns, GI symptoms abate, hemodynamic status stabilizes and diuresis ensues

    (+) rash: isles of white in the sea of red

    hematocrit stabilizes or may be lower due to dilutional effect of reabsorbed fluid

    WBC starts to rise recovery of platelet

    count occurs later

    Clinical phases of

    dengue fever

  • 5

    Tourniquet test

    Inflate blood pressure cuff to a point midway between systolic and diastolic pressure for 5 minutes

    After deflating the cuff, wait for the skin to return to its normal color, and then count the number of petechial visible in a one-inch- square area on the ventral surface of the forearm.

    Positive test: 20 or more petechial rash per 1 inch ((6.25 cm))

    (+) TT increases the

    probability of dengue (+) hemorrhagic

    manifestations enlarged and tender

    liver earliest abnormality:

    progressive decrease in

    total WBC

  • 6

    Classification according to severity (WHO classification)

    Renal function

    test that include(

    S.CrB.urea)

    CBC see for:

    ( WBC , HCT ,PLT )

    RBS

    Serology ( dengue antibodies IgM ,IgG when fever at 5th

    day or more , dengue

    antigen when fever less than 4 day )

    Liver function test mainly ( ALT ,AST , S,Albumin ,total bilirubin)

    Abdominal ultrasound

    Chest X-ray

    PT,PTT ,INR

    Urine exam for microscopic hematuria

    Other test to rule out

    Investigation should be done for any dengue

    case admission

  • 7

    Dengue Clinical Syndromes

    Undifferentiated fever

    Classic dengue Fever Headache, retro orbital pain Muscle and joint pain Nausea/vomiting Rash

    Hemorrhagic manifestations

    Dengue hemorrhagic fever (DHF) Fever, or recent history of acute fever

    Hemorrhagic manifestations Low platelet count (100,000/mm3 or less)

    Objective evidence of leaky capillaries

    Dengue shock syndrome (DSS) The four criteria for DHF +

    Evidence of circulatory failure

  • 8

    evidence of capillary leakage

    Evidence of

    circulatory failure

    Elevated hematocrit (defined as 20% or more over baseline, or a similar drop after volume replacement treatment); Low protein; or Pleural or other effusions.

    Indirect manifestation rapid and weak pulse; narrow pulse pressure of 20 mmHg or hypotension for age; and cold, clammy skin and altered mental status. (All three of these conditions must be met to indirectly demonstrate circulatory failure). Direct manifestation = frank shock.

  • 9

    Approach to the Management

    Groups A

    may be sent home

    tolerate adequate volumes of oral fluids and pass urine at least once every 6 hours

    no warning signs

    Groups B referred for

    in-hospital management

    with warning signs, co-existing conditions,

    with certain social circumstances

    Groups C require

    emergency treatment and urgent referral

    severe dengue (in critical phase)

  • 10

    Plan for group A:-

    Encourage intake of ORS, fruit juice and other fluids Paracetamol for fever Advise to come back if with

    no clinical improvement

    severe abdominal pain

    persistent vomiting

    cold and clammy extremities,

    lethargy or irritability or restlessness,

    bleeding

    not passing urine for more than 46 hours.

    Group B (with warning signs)

    Action Plan( Modified)

    N/S 500 - during 1hr then 1000 cc during 4h ( ASSESS HCT ) 500 cc during another 4hr 500 cc during 8h 500cc during 8hr

    Reassess Hematocrit remains the same or rise minimally {500 cc

    during 6 to 8 hourly)

    worsening vital signs and rising hematocrit 250 cc to 500cc during 1 hr then reassess

    Calculation assuming

    BW 45-50kg

  • 11

    N/S 500 - during 2hr then

    1000 cc during 4h

    500 cc during another 4hr

    500 cc during 8hr

    500cc during 8hr

    Monitor HCT 8-12hr

    NO

    yes

    HCT

    Given fresh whoole

    blood or packed RBC

    PLT transfusion given if less than 10000 without overt bleeding and

    normal or elevated HCT

    Group C

    Compensated Shock

    500- 1000 cc during 1hr.

    improve

    Increase

    decrease

    Compensated shock rapid and weak pulse; narrow pulse pressure of 20 mmHg or hypotension for age; and cold, clammy skin and altered mental status.

  • 12

    2n

    Crystalloid solution 500cc /hr N/S 500 - during 1hr then 1000 cc during 4h 500 cc during 4hr 500 cc during 8h 500cc during 8hr

    HCT 6hourly Monitor if improve decrease fluid if increase another bolus

    if decrease FWB/PRB

    Group C Hypovolemic shock

    HCT assess 1000 cc /15 minute

    Improve

    2nd bolus

    500 1000 -1hr Consider significant overt /occult blood

    FWB/PRBC

    yes NO HCT

    improve

    2nd

    HCT

    3rd

    bolus

    500 1000 cc 1hr

    improve NO 3rd

    HCT

    decrease increase

    yes

    NO

    decrease

    increase

    yes

  • 13

    dfd

    Criteria for discharge dengue case from hospital

    Absence of fever for 48 hours (without anti-fever therapy) and return of appetite

    Visible improvement in clinical picture, Stable hematocrit 3 days after recovery from

    shock

    Platelet 50,000mm

    No respiratory distress from pleural effusions/ascites

  • 14